Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00006228 · COMPLETED

Trial details

NCT number: NCT00006228
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2000-07-01
Primary completion: 2003-07-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.